Largest biotech by market cap

Amgen leads the 3 biotech ranked by market value, at $248.3B, ahead of Gilead Sciences ($210.9B) and Moderna ($84B). Figures as of 17 Nov 2026, 17:16 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
3
First
Amgen$248.3B
Median
$210.9B
Combined market value
$543.2B
Countries
1

Market values as of .

Largest biotech by market cap
#CompanyMarket cap ↓PriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health Care$248.3B$459.03 0.71% down 34% up United States
2Gilead SciencesGILD · Health Care$210.9B$170.07 1.49% up 32% up United States
3ModernaMRNA · Health Care$84B$207.59 3.57% down 764% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration.

Questions and answers

Which biotech rank first by market value?

Amgen ($248.3B), Gilead Sciences ($210.9B) and Moderna ($84B) are the top three of the 3 biotech ranked by market value as of 17 Nov 2026, 17:16 UTC.

How many biotech are in this ranking?

3 are ranked by market value.

What are these biotech worth together?

Their combined market value is $543.2B as of 17 Nov 2026, 17:16 UTC.

What does ranking by market value measure?

What the stock market values the whole company at: its share price times the number of its shares.

Cite this page

Funkfolio, “Largest biotech by market cap”, data as of 17 November 2026. https://funkfolio.com/companies/category/biotech

Underlying data: Yahoo Finance; SEC EDGAR.